CD19 and multiple sclerosis: In the animal model for multiple sclerosis, EAE, the transfer of regulatory IL-10 producing B cells (B10) into Cd19−/− B cell deficient mice reduces EAE severity and reduces autoantigen-specific CD4+ T cell proliferation and pro-inflammatory cytokine production (Yoshizaki et al., 2012).